Drug Information

Drug General Information
Drug ID
D0G6BG
Former ID
DNC013875
Drug Name
2-Benzylbenzo[f]chromen-3-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Formula
C20H14O2
Canonical SMILES
C1=CC=C(C=C1)CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O
InChI
1S/C20H14O2/c21-20-16(12-14-6-2-1-3-7-14)13-18-17-9-5-4-8-15(17)10-11-19(18)22-20/h1-11,13H,12H2
InChIKey
OOALWLFUSOVWMV-UHFFFAOYSA-N
PubChem Compound ID
10731937
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530009]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.